Intuitive Surgical Files Q2 2024 10-Q Report

Ticker: ISRG · Form: 10-Q · Filed: Jul 19, 2024 · CIK: 1035267

Sentiment: neutral

Topics: 10-Q, earnings, medical-devices

TL;DR

ISR G Q2 10-Q FILED. FINANCIALS AND OPS DETAILS OUT.

AI Summary

Intuitive Surgical Inc. filed its 10-Q report for the period ending June 30, 2024. The company, headquartered in Sunnyvale, CA, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. The filing covers financial performance and operational details for the second quarter and the first half of 2024.

Why It Matters

This filing provides investors with crucial financial and operational data for Intuitive Surgical, impacting investment decisions and market perception of the company's performance in the medical device sector.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240630, indicating the filing covers the period ending June 30, 2024.

What is the company's Central Index Key (CIK)?

The company's Central Index Key is 0001035267.

What is the Standard Industrial Classification (SIC) code for Intuitive Surgical Inc.?

The SIC code is 3842, categorized under Orthopedic, Prosthetic & Surgical Appliances & Supplies.

When was this 10-Q filing submitted to the SEC?

The filing was submitted on 20240719.

What is the company's state of incorporation?

The state of incorporation is Delaware (DE).

Filing Stats: 4,617 words · 18 min read · ~15 pages · Grade level 7.6 · Accepted 2024-07-19 17:03:43

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited): Condensed Consolidated Balance Sheets as of June 30, 2024 , and December 31, 2023 3 Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2024 , and 2023 4 Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 , and 2023 5 Notes to C ondensed C onsolidated F inancial S tatements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 48 Item 4.

Controls and Procedures

Controls and Procedures 48

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 49 Item 1A.

Risk Factors

Risk Factors 49 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 49 Item 3. Defaults Upon Senior Securities 49 Item 4. Mine Safety Disclosures 49 Item 5. Other Information 50 Item 6. Exhibits 51 Signature 52 2

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS INTUITIVE SURGICAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) in millions (except par values) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 3,036.7 $ 2,750.1 Short-term investments 1,720.5 2,473.1 Accounts receivable, net 1,109.1 1,130.2 Inventory 1,383.9 1,220.6 Prepaids and other current assets 404.1 314.0 Total current assets 7,654.3 7,888.0 Property, plant, and equipment, net 4,116.8 3,537.6 Long-term investments 2,925.9 2,120.0 Deferred tax assets 946.9 910.5 Intangible and other assets, net 658.0 636.7 Goodwill 348.0 348.7 Total assets $ 16,649.9 $ 15,441.5 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 194.4 $ 188.7 Accrued compensation and employee benefits 321.3 436.4 Deferred revenue 433.9 446.1 Other accrued liabilities 537.9 587.5 Total current liabilities 1,487.5 1,658.7 Other long-term liabilities 365.9 385.5 Total liabilities 1,853.4 2,044.2 Contingencies (Note 8) Stockholders' equity: Preferred stock, 2.5 shares authorized, $ 0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2024, and December 31, 2023 — — Common stock, 600.0 shares authorized, $ 0.001 par value, 355.3 shares and 352.3 shares issued and outstanding as of June 30, 2024, and December 31, 2023, respectively 0.4 0.4 Additional paid-in capital 9,149.7 8,576.4 Retained earnings 5,581.7 4,743.0 Accumulated other comprehensive loss ( 23.5 ) ( 12.2 ) Total Intuitive Surgical, Inc. stockholders' equity 14,708.3 13,307.6 Noncontrolling interest in joint venture 88.2 89.7 Total stockholders' equity 14,796.5 13,397.3 Total liabilities and stockholders' equity $ 16,649.9 $ 15,441.5 The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited). 3 INTUITIVE SURGICAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Three Months Ended Ju

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing